Lockheed Martin Reports Third Quarter 2026 Financial Results

Lockheed Martin reported Q3 2026 sales up 11% year over year to $20.7 billion and net earnings up 14% to $1.8 billion, or $7.97 per diluted share. Backlog reached a record $292.0 billion, up 27% since Q2, and the company raised its 2026 sales, EPS and free-cash-flow outlook for a second consecutive quarter; it also said it raised its dividend for the 24th consecutive year. Cash from operations fell to $3.4 billion from $3.7 billion, while the company warned that insufficient U.S. government authorization and funding for F-35 Lot 20 could hurt future results, cash flows and financial condition.

Analysis

The key read-through is a widening gap between demand visibility and cash realization. The exceptionally large backlog is not near-term revenue: its sharp step-up is heavily influenced by the multi-year PAC-3 award, so conversion depends on appropriations, contract execution, and production capacity. Missiles and Fire Control is the clearest operating-growth engine, but its quarterly margin was essentially flat year over year; the order surge therefore supports volume visibility more directly than near-term margin expansion.

Cash deserves more scrutiny than the headline earnings trajectory. Nine-month operating cash flow benefited from working-capital movements, while contract assets rose materially; that leaves delivery acceptance and customer-payment timing central to the raised full-year FCF outlook. Separately, F-35 lot negotiations have crossed into a funding/authorization issue: a prolonged impasse could absorb cash or constrain work even as Aeronautics sales benefit from higher program volume. That is a meaningful counterweight to the backlog narrative, not evidence of a consolidated liquidity crisis.

Over the next days, guidance and backlog can support sentiment, but valuation and positioning are unknown, so avoid assuming the beat is mispriced. Over 1–3 months, watch F-35 authorization, Q4 cash conversion, and evidence that missile ramps translate into deliveries. Over 6–18 months, capacity and supply-chain execution determine how much of the order book becomes profitable sales. RTX and Northrop Grumman are relevant defense-sector comparables, but this release alone does not establish a relative-value signal. The contrarian risk is treating record backlog as equivalent to durable near-term FCF; the bullish counterpoint is that multi-year missile demand may sustain production investment and revenue visibility beyond the next quarter.

Key Decisions for Investors

• Do not chase LMT solely on backlog or the guidance increase; without price and valuation context, treat the report as a modest fundamental positive rather than a stand-alone entry signal.
• Keep LMT on an add-on-weakness watchlist, contingent on confirmation that Q4 FCF reaches the implied full-year range and contract assets begin converting into customer cash. Reassess if cash guidance is cut or contract assets continue to rise without corresponding collections.
• Track F-35 lots 20+ authorization and funding as a near-term catalyst/risk. A timely funded agreement would reduce execution uncertainty; continued delay or disclosed adverse cash-flow effects would weaken the thesis.
• For a 1–3 month monitor, compare missile-program sales/profit growth with deliveries and working-capital needs, rather than extrapolating backlog growth. Evidence of ramp delays, margin deterioration, or missed FCF guidance would falsify the bullish read-through.